Difference between revisions of "Citalopram-bupropion"

From Psychiatrienet
Jump to: navigation, search
 
(3 intermediate revisions by 2 users not shown)
Line 3: Line 3:
 
| to = bupropion  
 
| to = bupropion  
 
| stop =  
 
| stop =  
* '''Day 1:''' gradually reduce dosage of citalopram/escitalopram to a maximum of 20 mg/ day resp. 10 mg/day, when this dosage is respectively > 20 mg/day and > 10 mg/day.
+
{{stopCitalopram14d}}
* '''Day 8:''' stop administration of citalopram/escitalopram
+
 
 
| start =  
 
| start =  
* '''Day 8:''' start bupropion in a normal dosage of 150 mg/day.
+
* '''Day 16:''' start bupropion in a normal dosage of 150 mg/day.
 
+
* ''' Day 23: ''' if necessary gradually increase the dosage of bupropion to target dose.
 
| info =  
 
| info =  
* The same applies to [[escitalopram]].}}
+
{{SSRI14d}}
 +
}}

Latest revision as of 13:19, 21 October 2015

Citalopram
Type Antidepressant
Group SSRI
links
ATC-code N06AB04
Medscape Citalopram
PubChem 2771
PubMed Citalopram
Kompas (Dutch) citalopram
Wikipedia citalopram
Bupropion
Type Antidepressant
Group other
links
ATC-code N06AX12
Medscape Bupropion
PubChem 444
PubMed Bupropion
Kompas (Dutch) Bupropion
Wikipedia Bupropion

Switch medication from citalopram to bupropion.

Nietinrijdenbord.png Stop citalopram
  • Day 1: reduce dosage of citalopram to a maximum of 20 mg/day
  • Day 8: reduce dosage of citalopram to 10 mg/day
  • Day 15: stop citalopram
Eenrichtingbord.png Start bupropion
  • Day 16: start bupropion in a normal dosage of 150 mg/day.
  • Day 23: if necessary gradually increase the dosage of bupropion to target dose.
Infobord.png More information
  • The reduction of the SSRI doses in 7-14 days could cause emotional instability, headache and flu-like symptoms. One could extend this period.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.